Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AbD Serotec, the research and diagnostic antibodies unit of MorphoSys, has entered into a license agreement with VU University Medical Center (VUmc) for worldwide exclusive rights to commercialise a number of antibody clones for research applications.
Subscribe to our email newsletter
The antibody clones include the reagents used for studying macrophage subsets in rats, the ‘ED series’ of antibodies.
The agreementis expected to strengthen AbD Serotec’s position as primary source of reagents for studying the innate immune system.
AbD Serotec head Dieter Feger said that they have decided to further expand their offering in innate immunity research and take an exclusive manufacturing license for a range of ED antibody clones from the VU University Medical Center.